This article is for premium subscribers!
To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!
If you are a premium subscriber that is not logged in, please login now.
SALEM – Proponents expect a bill that would force prescription drug manufacturers to be more transparent about price hikes to land soon on Gov. Kate Brown’s desk, putting Oregon at the forefront of efforts to fight against skyrocketing drug prices.
Oregon has agreed to settle with the pharmaceutical company, Pfizer, again over false, misleading or illegal marketing claims or promotions of its drugs.
California Gov. Gavin Newsom says he’s done waiting for the federal government to curtail the rising cost of prescription drugs.
Newsom has his own plan to ease that financial burden — one he hopes other states can join or replicate.
Medicare patients with multiple sclerosis face skyrocketing costs for treatment due to insurance regulations that force them to pay more out of pocket for generic drugs, a study has found.
President Donald Trump’s new pledge to crack down on “the global freeloading” in prescription drugs had a sense of déjà vu.
For years, most pharmacists couldn’t give customers even a clue about an easy way to save money on prescription drugs. But the restraints are coming off.
Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.
Oregon U.S. Sen. Ron Wyden again blasted the Trump administration on Monday over its proposed drug pricing plan.
Rep. Rob Nosse, D-Portland, touted his aggressive and innovative approach to tackling uncontrolled pharmaceutical costs on Thursday, calling on Oregon to lead where Congress has failed and other state-based reforms have fallen short.